Published in Ther Adv Neurol Disord on March 02, 2016
Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application. Semin Immunopathol (2016) 0.81
Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis. Dtsch Arztebl Int (2016) 0.75
Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. Neurol Sci (2017) 0.75
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med (1998) 4.65
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol (2009) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol (2011) 2.36
One can prevent post-partum MS relapses by exclusive breast feeding: commentary. Mult Scler (2013) 2.01
Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain (1995) 1.90
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol (2010) 1.70
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain (2004) 1.70
The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology (2005) 1.62
A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler (2007) 1.61
Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol (2008) 1.59
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol (2015) 1.57
Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol (2002) 1.57
Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol (2012) 1.52
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology (2012) 1.39
Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler (2011) 1.19
Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study. Mult Scler (2009) 1.18
Pregnancy, sex and hormonal factors in multiple sclerosis. Mult Scler (2014) 1.15
Is breast truly best? Estimating the effects of breastfeeding on long-term child health and wellbeing in the United States using sibling comparisons. Soc Sci Med (2014) 1.15
One can prevent post-partum MS relapses by exclusive breast feeding: no. Mult Scler (2013) 1.09
Corticosteroid use during pregnancy and risk of orofacial clefts. CMAJ (2011) 1.07
Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology (2012) 1.07
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events. BMJ Open (2014) 1.05
Neuromyelitis optica IgG causes placental inflammation and fetal death. J Immunol (2013) 1.05
Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology (2011) 1.04
Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord (2013) 1.01
Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series. CNS Drugs (2010) 1.00
Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol (2004) 0.99
Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Saf (2001) 0.97
Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med (2014) 0.95
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis. Mult Scler (2013) 0.93
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther Adv Neurol Disord (2012) 0.93
Experimental study of transplacental passage of alpha interferon by two assay techniques. Antimicrob Agents Chemother (1993) 0.92
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment. Ther Adv Neurol Disord (2015) 0.91
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder. Mult Scler (2015) 0.89
Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol (2011) 0.89
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study. Mult Scler (2014) 0.89
Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J Neuroendocrinol (2008) 0.87
Increased risk of multiple sclerosis relapse after in vitro fertilisation. J Neurol Neurosurg Psychiatry (2012) 0.87
Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol (2011) 0.86
Breastfeeding and multiple sclerosis relapses: a meta-analysis. J Neurol (2012) 0.86
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology (1996) 0.86
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis. Neurol Ther (2014) 0.86
Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler (2004) 0.86
Reverse causality behind the association between reproductive history and MS. Mult Scler (2013) 0.85
Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler (2012) 0.85
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis. J Neurol (2010) 0.85
Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg (1994) 0.85
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol (2012) 0.84
Reproductive decision making after the diagnosis of multiple sclerosis (MS). Mult Scler (2012) 0.84
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol (2014) 0.84
Pregnancy in multiple sclerosis. Eur Neurol (2014) 0.84
Artificial reproductive techniques in multiple sclerosis. Clin Immunol (2013) 0.84
Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs. Mult Scler (2011) 0.83
Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol (2008) 0.83
Breastfeeding is associated with lower risk for multiple sclerosis. Mult Scler (2012) 0.83
Multiple sclerosis and pregnancy in the 'treatment era'. Nat Rev Neurol (2015) 0.82
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. CNS Drugs (2015) 0.82
Birth hospitalization in mothers with multiple sclerosis and their newborns. Neurology (2013) 0.82
Vitamin D, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses. Arch Neurol (2010) 0.82
Multiple sclerosis and vitamin D during pregnancy and lactation. Acta Neurol Scand (2014) 0.80
Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler (2013) 0.80
Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry (2012) 0.80
Fecundity in women with multiple sclerosis: an observational mono-centric study. J Neurol (2015) 0.79
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis. J Neurol Sci (2011) 0.79
Pregnancy outcomes in patients exposed to interferon beta-1b. J Neurol Neurosurg Psychiatry (2014) 0.79
Birth outcomes of pregnancies fathered by men with multiple sclerosis. Mult Scler (2014) 0.79
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course. Clin Immunol (2013) 0.79
Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurol Scand Suppl (2006) 0.79
Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. Eur J Neurol (2007) 0.79
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue. BMJ Case Rep (2014) 0.78
Safety issues of biologics in pregnant patients with rheumatic diseases. Ann N Y Acad Sci (2014) 0.78
Multiple sclerosis in pregnancy. Continuum (Minneap Minn) (2014) 0.78
Natalizumab use during the third trimester of pregnancy. JAMA Neurol (2014) 0.78
One can prevent post-partum MS relapses by exclusive breast feeding: yes. Mult Scler (2013) 0.78
Transfer of natalizumab into breast milk in a mother with multiple sclerosis. J Hum Lact (2015) 0.78
Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol (2015) 0.78
Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis. Mult Scler (2014) 0.78
Transfer of methylprednisolone into breast milk in a mother with multiple sclerosis. J Hum Lact (2015) 0.77
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol (2014) 0.77
Better prognosis of multiple sclerosis in patients who experienced a full-term pregnancy. Eur Neurol (2012) 0.77
What do healthcare providers advise women with multiple sclerosis regarding pregnancy? Mult Scler Int (2014) 0.77
Does pregnancy alter the long-term course of multiple sclerosis? Ann Epidemiol (2014) 0.77
Natalizumab discontinuation and disease restart in pregnancy: a case series. Acta Neurol Scand (2015) 0.77
Mitoxantrone and etoposide in breast milk. Am J Hematol (1995) 0.77
Transfer of interferon β-1a into human breastmilk. Breastfeed Med (2011) 0.77
Pseudotumoral rebound of multiple sclerosis in a pregnant patient after stopping natalizumab. Mult Scler Relat Disord (2013) 0.77
Sex hormones and multiple sclerosis: another informative failure. Lancet Neurol (2015) 0.76
Congenital abnormalities and multiple sclerosis. BMC Neurol (2010) 0.76
Natalizumab treatment during pregnancy - effects on the neonatal immune system. Acta Neurol Scand (2012) 0.76
Serum anti-Müllerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis. Mult Scler (2014) 0.76
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients. Eur J Neurol (2014) 0.76
Neuroradiology in women of childbearing age. Continuum (Minneap Minn) (2014) 0.76
How safe is natalizumab during pregnancy? Mult Scler (2014) 0.76
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology (2015) 0.76
Role of socio-economic and reproductive factors in the risk of multiple sclerosis. Acta Neurol Scand Suppl (2015) 0.76
Committee Opinion No. 642: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. Obstet Gynecol (2015) 0.76
Long-term effects of exposure to disease-modifying drugs in the offspring of mothers with multiple sclerosis: a retrospective chart review. CNS Drugs (2013) 0.76
Multiple sclerosis and motherhood choice: an observational study in Portuguese women patients. Rev Neurol (2014) 0.76